Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-26 @ 1:13 PM
Study NCT ID:
NCT04862767
Status:
COMPLETED
Last Update Posted:
2024-01-31
First Post:
2021-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor
Sponsor:
Autotelicbio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-21
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-17
First Submit QC Date:
None
Study First Post Date:
2021-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-29
Last Update Post Date:
2024-01-31
Last Update Post Date Type:
ACTUAL